Andrew D. Hershey, MD, PhD, FAHS

My Biography & Research

Biography

Andrew Hershey, MD, PhD, FAHS, received his undergraduate degree at the University of Iowa, Iowa City, Iowa. He earned an honors degree in biochemistry; his research involved the enzyme kinetic properties of alcohol dehydrogenase in yeast.

After undergraduate school, Dr. Hershey attended the MD/PhD program at Washington University, St. Louis, Missouri. His PhD research thesis was entitled: "The Rat Substance P Receptor: cDNA and Genomic Cloning, Functional Expression, mRNA Distribution, and Mutational Analysis of Desensitization Responses."

After earning his MD and PhD, Dr. Hershey was an intern and resident in pediatrics at St. Louis Children's Hospital, St. Louis, MO. He then was an adult neurology resident at Barnes-Jewish Hospital, St. Louis, MO, followed by his child neurology fellowship at St. Louis Children's Hospital, St. Louis, MO.

After his fellowship, Dr. Hershey joined the faculty at Cincinnati Children's Hospital Medical Center, Ohio, within the University of Cincinnati College of Medicine, where he is director of the Headache Center.

Dr. Hershey's research interests currently include the improved diagnosis and treatment of childhood headache disorders, characterization of outcome responses, studies in new pharmacological and non-pharmacological treatment regimes, and the neurogenetics of migraines.

Clinical Interests

Headaches; migraines; neurogenetics; neurometabolic disorders

Research Interests

Epidemiology; diagnostic criteria; treatment evaluation; outcome responses; quality of life issues; pharmaceutical trials; and neurogenetics of childhood headaches

Academic Affiliation

Professor, UC Department of Pediatrics

Departments

Neurology, Headache Medicine, Neurology

Science Blog

Research from Cincinnati Children’s Leads to New Migraine Treatment Guidelines

Andrew D. Hershey, MD, PhD, FAHS8/22/2019

CHAMP Study Challenges Medication-Driven Approach to Migraine Care

Andrew D. Hershey, MD, PhD, FAHS6/30/2019

My Locations

Mason

Mason

9560 Children's Drive

Mason, Ohio 45040

1-513-636-6800

Directions From

My Education

BS: University of Iowa, Iowa City, IA, 1985.

MD: Washington University, St. Louis, MO, 1992.

PhD: Washington University, St. Louis, MO, 1992.

Residency: St. Louis Childrens Hospital, St. Louis, MO, 1993-1994; Barnes-Jewish Hospital, St. Louis, MO,1994-1995.

Fellowship: St. Louis Childrens Hospital, St. Louis, MO, 1995-1997.

Certification: Neurology with special competence in child neurology, 1998, recertified 2008; Headache Medicine, 2006.

My Publications

Selected Publication

CGRP - The Next Frontier for Migraine. Hershey, AD. The New England journal of medicine. 2017; 377:2190-2191.

Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. Powers, SW; Coffey, CS; Chamberlin, LA; Ecklund, DJ; Klingner, EA; Yankey, JW; Korbee, LL; Porter, LL; Hershey, AD; Investigators, CH A M P. The New England journal of medicine. 2017; 376:115-124.

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Oskoui, M; Pringsheim, T; Billinghurst, L; Potrebic, S; Gersz, EM; Gloss, D; Holler-Managan, Y; Leininger, E; Licking, N; Mack, K; et al. Neurology. 2019; 93:500-509.

Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Oskoui, M; Pringsheim, T; Holler-Managan, Y; Potrebic, S; Billinghurst, L; Gloss, D; Hershey, AD; Licking, N; Sowell, M; Victorio, MC; et al. Neurology. 2019; 93:487-499.

Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network. Zouk, H; Venner, E; Muzny, DM; Lennon, NJ; Rehm, HL; Gibbs, RA; Walker, K; Gordon, AS; Bowser, M; Harden, MV; et al. The American Journal of Human Genetics. 2019; 105:588-605.

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Oskoui, M; Pringsheim, T; Billinghurst, L; Potrebic, S; Gersz, EM; Gloss, D; Holler-Managan, Y; Leininger, E; Licking, N; Mack, K; et al. Headache. 2019; 59:1144-1157.

Practice guideline update summary: Acute treatment of migraine in children and adolescents Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Oskoui, M; Pringsheim, T; Holler-Managan, Y; Potrebic, S; Billinghurst, L; Gloss, D; Hershey, AD; Licking, N; Sowell, M; Victorio, MC; et al. Headache. 2019; 59:1158-1173.

New Guidelines: Interpretation, Application and the Future. Hershey, AD; Oskoui, M; Pringsheim, T; Holler-Managan, Y; Potrebic, S; Billinghurst, L; Gloss, D; Licking, N; Sowell, M; Victorio, MC; et al. Headache. 2019; 59:1133-1143.

Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition. Abu-Arafeh, I; Hershey, AD; Diener, H; Tassorelli, C; Comm, CT S; Comm, CA S; Soc, IH. Cephalalgia: an international journal of headache. 2019; 39:803-816.

Increased pain sensitivity but normal pain modulation in adolescents with migraine. Nahman-Averbuch, H; Leon, E; Hunter, BM; Ding, L; Hershey, AD; Powers, SW; King, CD; Coghill, RC. Pain. 2019; 160:1019-1028.